Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Evotec Affirms FY2025 Sales Guidance of $861.690M-$907.042M

Author: Benzinga Newsdesk | November 05, 2025 03:28am
Evotec (NASDAQ:EVO) affirms FY2025 sales outlook from $861.690 million-$907.042 million to $861.690 million-$907.042 million.

Posted In: EVO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist